Vireo Growth Inc. (VREOF)
OTCMKTS · Delayed Price · Currency is USD
0.5257
+0.0114 (2.23%)
At close: Feb 6, 2026
Vireo Growth Revenue
Vireo Growth had revenue of $91.66M in the quarter ending September 30, 2025, with 264.21% growth. This brings the company's revenue in the last twelve months to $189.28M, up 92.10% year-over-year. In the year 2024, Vireo Growth had annual revenue of $99.38M with 12.77% growth.
Revenue (ttm)
189.28M
Revenue Growth
+92.10%
P/S Ratio
3.02
Revenue / Employee
402.73K
Employees
520
Market Cap
571.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 99.38M | 11.25M | 12.77% |
| Dec 31, 2023 | 88.13M | 13.51M | 18.10% |
| Dec 31, 2022 | 74.63M | 20.18M | 37.06% |
| Dec 31, 2021 | 54.45M | 5.23M | 10.64% |
| Dec 31, 2020 | 49.21M | 19.26M | 64.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |
Vireo Growth News
- 2 days ago - 3 Things You Need to Know If You Buy Vireo Growth Today - The Motley Fool
- 11 days ago - Vireo Growth Inc. Enters into Non-Binding Memorandum of Understanding to Acquire The Hawthorne Gardening Company from ScottsMiracle-Gro - GlobeNewsWire
- 7 weeks ago - Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze - GlobeNewsWire
- 7 weeks ago - Vireo Growth Inc. Enters into Definitive Agreement to Acquire Certain Assets of PharmaCann Inc. - GlobeNewsWire
- 3 months ago - Vireo Growth Inc. (VREOF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Vireo Growth Inc. to Release Third Quarter 2025 Results on November 12, 2025 - GlobeNewsWire
- 3 months ago - Vireo Growth Inc. and Verano Holdings Corp. Announce Resolution of Litigation Matters - GlobeNewsWire
- 4 months ago - Vireo Growth Inc. Announces Closing of Acquisition of Outstanding Senior Secured Convertible Notes of Schwazze - GlobeNewsWire